ID CASB_HUMAN Reviewed; 226 AA. AC P05814; Q4VAZ9; Q9UCM5; DT 01-NOV-1988, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1992, sequence version 4. DT 24-JAN-2024, entry version 189. DE RecName: Full=Beta-casein; DE Flags: Precursor; GN Name=CSN2; Synonyms=CASB; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2387396; DOI=10.1016/0014-5793(90)81142-b; RA Loennerdal B., Bergstroem S., Andersson Y., Hjalmarsson K., Sundqvist A.K., RA Hernell O.; RT "Cloning and sequencing of a cDNA encoding human milk beta-casein."; RL FEBS Lett. 269:153-156(1990). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Placenta; RX PubMed=8112603; DOI=10.1016/0378-1119(94)90754-4; RA Hansson L., Edlund A., Johansson T., Hernell O., Stroemqvist M., RA Lindquist S., Loennerdal B., Bergstroem S.; RT "Structure of the human beta-casein encoding gene."; RL Gene 139:193-199(1994). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Mammary gland; RA Menon R.S.; RL Submitted (OCT-1989) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Placenta; RA Kwiatkowski D.J.; RT "A high resolution linkage map of human 9q34.1."; RL Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 16-226, AND PHOSPHORYLATION AT THR-18; SER-21; SER-23; RP SER-24 AND SER-25. RX PubMed=6715339; DOI=10.1016/s0021-9258(17)42966-8; RA Greenberg R., Groves M.L., Dower H.J.; RT "Human beta-casein. Amino acid sequence and identification of RT phosphorylation sites."; RL J. Biol. Chem. 259:5132-5138(1984). RN [7] RP PROTEIN SEQUENCE OF 18-33, PHOSPHORYLATION AT THR-18; SER-21; SER-23; RP SER-24 AND SER-25, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=18847231; DOI=10.1021/pr800387s; RA Poth A.G., Deeth H.C., Alewood P.F., Holland J.W.; RT "Analysis of the human casein phosphoproteome by 2-D electrophoresis and RT MALDI-TOF/TOF MS reveals new phosphoforms."; RL J. Proteome Res. 7:5017-5027(2008). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 161-226. RC TISSUE=Mammary gland; RX PubMed=2717418; DOI=10.1093/nar/17.7.2869; RA Menon R.S., Ham R.G.; RT "Human beta-casein: partial cDNA sequence and apparent polymorphism."; RL Nucleic Acids Res. 17:2869-2869(1989). RN [9] RP PROTEIN SEQUENCE OF 176-215. RX PubMed=1369431; DOI=10.1271/bbb.56.1140; RA Azuma N., Yamauchi K.; RT "Plasmin cleavage of human beta-casein."; RL Biosci. Biotechnol. Biochem. 56:1140-1141(1992). CC -!- FUNCTION: Important role in determination of the surface properties of CC the casein micelles. CC -!- INTERACTION: CC P05814; Q14192: FHL2; NbExp=4; IntAct=EBI-1642112, EBI-701903; CC P05814; Q9UHD9: UBQLN2; NbExp=6; IntAct=EBI-1642112, EBI-947187; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Mammary gland specific. Secreted in milk. CC -!- PTM: Form 1-P is phosphorylated once; half of the molecules are CC phosphorylated on Ser-24, half on Ser-25. {ECO:0000269|PubMed:18847231, CC ECO:0000269|PubMed:6715339}. CC -!- SIMILARITY: Belongs to the beta-casein family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Of buttons, digestion and CC glue - Issue 16 of November 2001; CC URL="https://web.expasy.org/spotlight/back_issues/016"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X55739; CAA39270.1; -; mRNA. DR EMBL; AF027807; AAC82978.1; -; Genomic_DNA. DR EMBL; X17070; CAA34916.1; -; mRNA. DR EMBL; BC069554; AAH69554.1; -; mRNA. DR EMBL; BC096194; AAH96194.1; -; mRNA. DR EMBL; BC096195; AAH96195.1; -; mRNA. DR EMBL; BC096196; AAH96196.1; -; mRNA. DR EMBL; BC096197; AAH96197.1; -; mRNA. DR EMBL; X13766; CAA32017.1; -; mRNA. DR CCDS; CCDS3532.1; -. DR PIR; I53730; KBHU. DR RefSeq; NP_001289699.1; NM_001302770.1. DR RefSeq; NP_001882.1; NM_001891.3. DR RefSeq; XP_016863249.1; XM_017007760.1. DR AlphaFoldDB; P05814; -. DR SMR; P05814; -. DR BioGRID; 107834; 45. DR IntAct; P05814; 15. DR MINT; P05814; -. DR STRING; 9606.ENSP00000341030; -. DR Allergome; 1064; Hom s 8. DR iPTMnet; P05814; -. DR PhosphoSitePlus; P05814; -. DR BioMuta; CSN2; -. DR DMDM; 115661; -. DR MassIVE; P05814; -. DR PaxDb; 9606-ENSP00000341030; -. DR PeptideAtlas; P05814; -. DR ProteomicsDB; 51861; -. DR Antibodypedia; 24273; 252 antibodies from 24 providers. DR DNASU; 1447; -. DR Ensembl; ENST00000353151.4; ENSP00000341030.3; ENSG00000135222.7. DR GeneID; 1447; -. DR KEGG; hsa:1447; -. DR MANE-Select; ENST00000353151.4; ENSP00000341030.3; NM_001891.4; NP_001882.1. DR AGR; HGNC:2447; -. DR CTD; 1447; -. DR DisGeNET; 1447; -. DR GeneCards; CSN2; -. DR HGNC; HGNC:2447; CSN2. DR HPA; ENSG00000135222; Tissue enriched (breast). DR MIM; 115460; gene. DR neXtProt; NX_P05814; -. DR OpenTargets; ENSG00000135222; -. DR PharmGKB; PA26950; -. DR VEuPathDB; HostDB:ENSG00000135222; -. DR eggNOG; ENOG502RU0R; Eukaryota. DR GeneTree; ENSGT00390000001890; -. DR HOGENOM; CLU_106775_0_0_1; -. DR InParanoid; P05814; -. DR OMA; EIMEVPK; -. DR OrthoDB; 4933674at2759; -. DR PhylomeDB; P05814; -. DR TreeFam; TF336929; -. DR PathwayCommons; P05814; -. DR Reactome; R-HSA-1251985; Nuclear signaling by ERBB4. DR SignaLink; P05814; -. DR BioGRID-ORCS; 1447; 12 hits in 1126 CRISPR screens. DR GeneWiki; CSN2; -. DR GenomeRNAi; 1447; -. DR Pharos; P05814; Tbio. DR PRO; PR:P05814; -. DR Proteomes; UP000005640; Chromosome 4. DR RNAct; P05814; Protein. DR Bgee; ENSG00000135222; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 37 other cell types or tissues. DR ExpressionAtlas; P05814; baseline and differential. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IDA:UniProtKB. DR GO; GO:0005509; F:calcium ion binding; TAS:ProtInc. DR GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:CAFA. DR GO; GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc. DR GO; GO:0006816; P:calcium ion transport; TAS:ProtInc. DR GO; GO:0007595; P:lactation; IDA:UniProtKB. DR GO; GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IDA:CAFA. DR InterPro; IPR001588; Casein. DR InterPro; IPR016345; Casein_beta. DR InterPro; IPR031305; Casein_CS. DR PANTHER; PTHR11500; BETA CASEIN; 1. DR PANTHER; PTHR11500:SF0; BETA-CASEIN; 1. DR Pfam; PF00363; Casein; 1. DR PIRSF; PIRSF002372; Beta-casein; 1. DR PROSITE; PS00306; CASEIN_ALPHA_BETA; 1. DR Genevisible; P05814; HS. PE 1: Evidence at protein level; KW Direct protein sequencing; Milk protein; Phosphoprotein; KW Reference proteome; Secreted; Signal. FT SIGNAL 1..15 FT /evidence="ECO:0000269|PubMed:6715339" FT CHAIN 16..226 FT /note="Beta-casein" FT /evidence="ECO:0000269|PubMed:6715339" FT /id="PRO_0000004475" FT MOD_RES 18 FT /note="Phosphothreonine; in form 5-P" FT /evidence="ECO:0000269|PubMed:18847231, FT ECO:0000269|PubMed:6715339" FT MOD_RES 21 FT /note="Phosphoserine; in form 4-P and form 5-P" FT /evidence="ECO:0000269|PubMed:18847231, FT ECO:0000269|PubMed:6715339" FT MOD_RES 23 FT /note="Phosphoserine; in form 3-P, form 4-P and form 5-P" FT /evidence="ECO:0000269|PubMed:18847231, FT ECO:0000269|PubMed:6715339" FT MOD_RES 24 FT /note="Phosphoserine; in form 1-P, form 2-P, form 3-P, form FT 4-P and form 5-P" FT /evidence="ECO:0000269|PubMed:18847231, FT ECO:0000269|PubMed:6715339" FT MOD_RES 25 FT /note="Phosphoserine; in form 1-P, form 2-P, form 3-P, form FT 4-P and form 5-P" FT /evidence="ECO:0000269|PubMed:18847231, FT ECO:0000269|PubMed:6715339" FT CONFLICT 30 FT /note="T -> P (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 34 FT /note="Missing (in Ref. 1; CAA39270)" FT /evidence="ECO:0000305" FT CONFLICT 48..50 FT /note="EDE -> TDQ (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 120 FT /note="S -> Q (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 133 FT /note="L -> V (in Ref. 3; CAA34916)" FT /evidence="ECO:0000305" FT CONFLICT 140 FT /note="H -> Q (in Ref. 3; CAA34916)" FT /evidence="ECO:0000305" FT CONFLICT 149 FT /note="L -> S (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 173 FT /note="Q -> E (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 182..184 FT /note="QVV -> EVL (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 188 FT /note="Q -> V (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 207 FT /note="T -> P (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 214..222 FT /note="TQPLAPVHN -> PEPSTTZABH (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 226 AA; 25382 MW; 2619C524EA1358E8 CRC64; MKVLILACLV ALALARETIE SLSSSEESIT EYKQKVEKVK HEDQQQGEDE HQDKIYPSFQ PQPLIYPFVE PIPYGFLPQN ILPLAQPAVV LPVPQPEIME VPKAKDTVYT KGRVMPVLKS PTIPFFDPQI PKLTDLENLH LPLPLLQPLM QQVPQPIPQT LALPPQPLWS VPQPKVLPIP QQVVPYPQRA VPVQALLLNQ ELLLNPTHQI YPVTQPLAPV HNPISV //